Private equity firm KKR will buy Pfizer’s Capsugel business for $2.375 billion in cash, the firms revealed Monday morning in a joint statement. Capsugel generated about $750 million in revenue in 2010 ...

NEW YORK — Pfizer Inc. said Monday it will sell its Capsugel capsule-making business to private equity firm Kohlberg Kravis Robert & Co. for $2.38 billion in cash. In October, Pfizer said it would ...

In the first part of this interview, Romanski tells PharmTech Group that while the field of oral dosage forms has not grown ...

Morristown, N.J. – April 28, 2014 – Capsugel today announced an agreement with Chiasma, Inc., wherein Capsugel's Dosage Form Solutions (DFS) business unit is scaling up manufacturing for the only ...

Capsugel’s intrinsically enteric capsule technology provides enteric protection and delayed release without a functional coating. Merck’s Parteck SRP 80 sustained-release excipient is well suited for ...

Pfizer, which recently told Wall Street it planned to slim down its business, said it would sell off capsule-maker Capsugel to the private equity group KKR for nearly $2.38 billion. Capsugel makes a ...

I was going to title this post "Big or Small We Track Them All" but on second thought it seemed too wordy and just a little bit confusing. Pharmaceutical giant Pfizer (PFE) announced today that it is ...

Capsugel, Xcelience and Powdersize have announced that the three companies have entered into a definitive agreement under which Capsugel will acquire both Xcelience and Powdersize. The transaction, ...

Pfizer (PFE) on Monday began executing what could be the start of two years of asset sales: The New York-based drugmaker said it agreed to sell its Capsugel business for $2.375 billion in cash to ...

Morristown, NJ and Bornem, Belgium, November 13, 2012 – Capsugel announced today that its Colmar manufacturing facility in France received its European Organic certification for the production of ...

Drug delivery solutions company Capsugel said Tuesday it has completed the acquisitions of two companies announced late last year.The finalization of the deals for Xcelience and Powdersize means the ...

NEW YORK -- Pfizer Inc. said Monday it will sell its Capsugel capsule-making business to private equity firm Kohlberg Kravis Robert & Co. for $2.38 billion in cash. In October, Pfizer said it would ...